Replies to post #688412 on NorthWest Biotherapeutics Inc (NWBO)

[User-840664]

""" Nature publication…. Could be just ahead."""
So could bankruptcy, it could substantially change the narrative, overnight.
NWBO could file bankruptcy, have Revimmune take it over for nothing while management retains all their shares in the new entity...
Just thinking my opinions out loud here...

Paul Allen’s Charter Stiffs Common Shareholders
Allen, 55, holds some of that debt that can be converted to stock and will retain voting control of the company.
For Allen, a billionaire recently ranked by Forbes as the 12th richest man in America with a net worth of $16 billion, the deal allows Charter to live for another day. For common stockholders, though, the bet on Allen was a bust
In the process, Charter left its common stockholders holding an empty bag.
How does Paul Allen remain the main shareholder while all of the shareholders’ stock is worthless? THIS SOUNDS LIKE ANOTHER RIP OFF,


https://www.eweek.com/it-management/paul-allen-s-charter-stiffs-common-shareholders/

[Investor082]

Nothing changes our fortune outside a large non dilutive big pharma investment. JAMA, TLD, MIA all took us in the reverse direction. Even UK MHRA approvals upside will be short lived, if big pharma announcement doesn’t come shortly thereafter.